PEP-Therapy Competitors and Similar CompaniesClear all
PEP-Therapy's competitors and similar companies include Aeglea and ISA Pharmaceuticals.
 PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | ||
Founding Date | Founding Date 2014 | Founding Date 2013 | Founding Date 2004 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Paris, FR HQ Évry, FR | Locations Austin, US HQ | Locations HQ |
Employees | Employees 14 | Employees 65117% increase | Employees 517% decrease |
Funding | |||
Latest funding round | Latest funding round $ 3m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 30.8m (about 5 years ago) |
Total funding raised | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 41.2m |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View company
ISA Pharmaceuticals
HQ
Employees
5↓ 17% decrease
ISA Pharmaceuticals is an immunotherapy company.
View company